Real-world data firm Litmus Health published its first census of wearable devices for clinical research.

Respiratory care specialist Vapotherm raised $56 million in an IPO on the New York Stock Exchange under the symbol VAPO.

Livongo and the University of California, San Francisco, launched a randomized, controlled trial that will recruit 300 adults with Type 2 diabetes.

Days after poaching a health system executive to pull together its disparate healthcare ventures, Google moved to reabsorb DeepMind’s health business.

Nyxoah has raised another €15 million (about $17 million) in financing to help commercialize its nerve stimulation treatment for sleep apnea.

Eko's AI could allow a broader number of physicians to digitally screen patients for heart murmurs without needing a trained cardiologist.

Medtronic’s final, five-year study data showed the durability of its drug-coated angioplasty balloon in peripheral artery disease.

Fierce 15 winner MaxQ AI received an FDA clearance for its artificial intelligence software that rapidly detects brain bleeds in CT scans.